← Back to Search

Cash Transfer

Cash Transfer for Cardiovascular Disease (PGI Trial)

N/A
Waitlist Available
Led By Christina A Roberto, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up once all study appointments are completed, ed visit data will be collected through the data analytics center for the 3-month period before baseline, and the 3-month period after baseline.
Awards & highlights

PGI Trial Summary

This trial aims to assess the effects of giving cash to people living with chronic disease in poverty to help improve their health and financial outcomes.

PGI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~once all study appointments are completed, ed visit data will be collected through the data analytics center for the 3-month period before baseline, and the 3-month period after baseline.
This trial's timeline: 3 weeks for screening, Varies for treatment, and once all study appointments are completed, ed visit data will be collected through the data analytics center for the 3-month period before baseline, and the 3-month period after baseline. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in adherence to medication refills scale
Change in financial well-being scale
Change in food security category
+5 more
Secondary outcome measures
Change in adherence to taking medications scale
Change in alcohol use scale
Change in all health care expenditures
+7 more

PGI Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cash TransferExperimental Treatment1 Intervention
Participants will receive $125 every 2 weeks for 8 payments via ClinCard, for a total of $1000.
Group II: ControlActive Control1 Intervention
No intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cash Transfer
2013
N/A
~1500

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,988 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,005,014 Total Patients Enrolled
Christina A Roberto, PhDPrincipal InvestigatorUniversity of Pennsylvania
10 Previous Clinical Trials
14,080 Total Patients Enrolled

Media Library

Cash Transfer (Cash Transfer) Clinical Trial Eligibility Overview. Trial Name: NCT05838027 — N/A
Cardiovascular Disease Research Study Groups: Control, Cash Transfer
Cardiovascular Disease Clinical Trial 2023: Cash Transfer Highlights & Side Effects. Trial Name: NCT05838027 — N/A
Cash Transfer (Cash Transfer) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05838027 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any fresh participants being enlisted for this experiment?

"As per the details on clinicaltrials.gov, this trial is not recruiting at present. Initially posted in April 4th of 2023 and last modified on 18th, it currently has no openings for participants. There are however 418 other trials actively enrolling patients right now."

Answered by AI

What are the chief aims of this trial?

"This clinical trial focuses on the alteration in utility security category as its primary objective, to be evaluated during a one hour session at baseline and three months. Secondary goals of this research include shifts from baseline in number of non-emergency department visits recorded through an Electronic Health Record, Alcohol Use Disorders Identification Test scores (0-12; higher values denote greater use), and Cigarette Dependence Scale results (short version; 5-25 with larger numbers correlating to increased dependence)."

Answered by AI
~50 spots leftby Apr 2025